Rifabutin Loaded Biogenic Silver Nanoparticles: Development, Characterization, and Evaluation of Antidiabetic Activity in Streptozotocin Induced Diabetic Rats.

Authors

Ayushi Maurya, Mohd Ibrahim Khan, Saif Mohammed Saleh Ansari, Mohd Faiyaz Khan, Faten F Bin Dayel, Wedad Mawkili, Norah A Ghazwani, Nazia Khan, Shanti Bhushan Mishra, Saim Kidwai, Danish Ahmed

Published in

Chemistry & biodiversity. Volume 23. Issue 8. Pages e03503.

Abstract

Diabetes mellitus characterizes a key universal health concern associated with severe metabolic complications. In this current study, a biogenic approach was employed to synthesize silver nanoparticles (AgNPs) using rifabutin as both a reducing and stabilizing agent. The resulting Rifabutin-AgNPs were thoroughly characterized by UV-vis spectroscopy, x-ray diffraction (XRD), scanning electron microscopy (SEM), and Fourier-transform infrared spectroscopy (FTIR), confirming their crystalline nature and functional group interactions responsible for nanoparticle stabilization. The antidiabetic potential of the synthesized Rifabutin-AgNPs was evaluated in streptozotocin (STZ)-induced diabetic rats. Oral administration of Rifabutin-AgNPs (5 and 10 mg/kg) for 14 days produced a significant, dose-dependent reduction in blood glucose levels, improved serum lipid profiles, and normalized hepatic transaminase (SGOT and SGPT) activities compared with untreated diabetic controls. The superior therapeutic efficacy of Rifabutin-AgNPs over pure rifabutin highlights the potential of this green synthesized nanoformulation as an efficient platform for diabetes management at the chemical biological interface.

PMID:
42603284
Bibliographic data and abstract were imported from PubMed on 16 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.